Jan 12 (Reuters) - Chr Hansen Holding A/S CHRH.CO :
* CHR. HANSEN HOLDING A/S INTERIM REPORT Q1 2022/23
* ON DECEMBER 12, 2022 CHR. HANSEN AND NOVOZYMES ANNOUNCED
THAT
TWO COMPANIES HAD ENTERED INTO AN AGREEMENT TO CREATE A LEADING
GLOBAL BIOSOLUTIONS PARTNER THROUGH A STATUTORY MERGER
* WORK HAS BEEN INITIATED TO SEEK CUSTOMARY MERGER CONTROL
AND
OTHER REGULATORY APPROVALS FROM RELEVANT AUTHORITIES, WHILE
EXTRAORDINARY GENERAL MEETING FOR SHAREHOLDER APPROVAL IS
CURRENTLY EXPECTED TO BE HELD IN FIRST HALF OF CALENDAR YEAR
2023
Source text for Eikon: ID:nGNE9y5BYz
Further company coverage: CHRH.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))